HEPION PHARMACEUTICALS, INC. Preferred Stock, Accretion of Redemption Discount
HEPION PHARMACEUTICALS, INC. (HEPA) reported Preferred Stock, Accretion of Redemption Discount of $5.82 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2021-11-15
- HEPION PHARMACEUTICALS, INC. preferred stock, accretion of redemption discount for the quarter ending 2021-09-30 was $529.00, a 89.99% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. preferred stock, accretion of redemption discount for the quarter ending 2021-06-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. preferred stock, accretion of redemption discount for the quarter ending 2021-03-31 was $5.29K.
- HEPION PHARMACEUTICALS, INC. preferred stock, accretion of redemption discount for the quarter ending 2020-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. preferred stock, accretion of redemption discount for fiscal 2020 was $5.29K, a 99.89% decline from fiscal 2019.
- HEPION PHARMACEUTICALS, INC. preferred stock, accretion of redemption discount for fiscal 2019 was $4.67M.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 6 month | Preferred Stock, Accretion of Redemption Discount 9 month | Preferred Stock, Accretion of Redemption Discount 12 month |
|---|---|---|---|---|
| 2021-09-30 | $529.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $529.00 derived: sum of 2 quarters · filed 2021-11-15 | $5.82K 10-Q · filed 2021-11-15 | $5.82K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $5.29K 10-Q · filed 2021-08-16 | $5.29K derived: sum of 3 quarters · filed 2021-08-16 | $10.57K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-03-31 | $5.29K 10-Q · filed 2021-05-14 | $5.29K derived: sum of 2 quarters · filed 2021-05-14 | $10.57K derived: sum of 3 quarters · filed 2021-11-15 | $10.57K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $5.29K derived: sum of 2 quarters · filed 2021-11-15 | $5.29K derived: sum of 3 quarters · filed 2021-11-15 | $5.29K 10-K · filed 2021-03-31 |
| 2020-09-30 | $5.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $5.29K derived: sum of 2 quarters · filed 2021-11-15 | $5.29K 10-Q · filed 2021-11-15 | $5.29K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2021-08-16 | $8.46K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $8.46K derived: sum of 3 quarters · filed 2021-05-14 | $4.65M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $8.46K derived: sum of 2 quarters · filed 2021-03-31 | $4.65M derived: sum of 3 quarters · filed 2021-03-31 | $4.67M 10-K · filed 2021-03-31 |
| 2019-09-30 | $8.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $4.65M derived: sum of 2 quarters · filed 2020-11-16 | $4.67M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $4.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $4.67M 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $24.32K 10-Q · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |